% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Strobel:285668,
author = {T. Strobel$^*$ and M. Weber$^*$ and N. Heber$^*$ and A.
Holzer$^*$ and K. Hoppe-Seyler$^*$ and F. Hoppe-Seyler$^*$},
title = {{R}evisiting the role of endogenous {STAT}3 in
{HPV}-positive cervical cancer cells.},
journal = {Journal of medical virology},
volume = {95},
number = {11},
issn = {0146-6615},
address = {Bognor Regis [u.a.]},
publisher = {Wiley},
reportid = {DKFZ-2023-02491},
pages = {e29230},
year = {2023},
note = {#EA:F065#LA:F065# / 2023 Nov;95(11):e29230},
abstract = {Novel treatment options for human papillomavirus
(HPV)-induced cancers are urgently required. The oncogenic
transcription factor signal transducer and activator of
transcription 3 (STAT3) is considered to be constitutively
active in HPV-positive cervical cancer cells and essential
for their proliferation. Moreover, STAT3 was reported to
undergo mutually stimulatory interactions with the HPV E6/E7
oncogenes. Thus, inhibiting STAT3 in HPV-positive cancer
cells is under discussion to provide a powerful novel
therapeutic strategy. We here show that the antifungal drug
ciclopirox destabilizes the STAT3 protein by acting as an
iron chelator. However, by exploring the functional
consequences of STAT3 inhibition in HPV-positive cancer
cells, we obtained several unexpected results. Chemical
STAT3 inhibitors heterogeneously affect cervical cancer cell
proliferation and those which act antiproliferative also
block the growth of STAT3 knockout cells, indicating
induction of off-target effects. In contrast to several
chemical inhibitors, genetic inhibition of STAT3 expression
by either RNA interference or the CRISPR/Cas9 method does
not appreciably affect cervical cancer cell proliferation.
Transcriptome analyses indicate that blocking STAT3
expression in HPV-positive cancer cells has very limited
effects on putative STAT3 target genes. Although the
targeted inhibition of specific growth-promoting signaling
pathways leads to a feedback activation of STAT3 in cervical
cancer cells via Janus kinase 1/2, this does not lead to
treatment resistance. Moreover, we did not obtain
experimental evidence for a STAT3-linked activation of HPV
E6/E7 oncogene expression or, vice versa, an E6/E7-dependent
activation of STAT3, at endogenous conditions in cervical
cancer cells. Collectively, these findings question the
essential role of STAT3 in cervical cancer cell
proliferation and the strategy to inhibit STAT3 in these
cells for therapeutic purposes.},
keywords = {MEK (Other) / PI3K (Other) / STAT3 (Other) / cervical
cancer (Other) / ciclopirox (Other) / human papillomavirus
(Other)},
cin = {F065},
ddc = {610},
cid = {I:(DE-He78)F065-20160331},
pnm = {316 - Infektionen, Entzündung und Krebs (POF4-316)},
pid = {G:(DE-HGF)POF4-316},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:38009614},
doi = {10.1002/jmv.29230},
url = {https://inrepo02.dkfz.de/record/285668},
}